Skip to main content
OpenTrials
Completed

NCT Number: NCT04767100

Study of the Impact of a Social Telepresence Robot on Social Isolation and Loneliness of the Elderly at Home

The main purpose of this monocentric, prospective study is to measure the impact of the implementation of a robotic social telepresence tool, during three months at home, on the feeling of loneliness and social isolation of the elderly

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Elderly People Living at Home With an Internet Connection at Home

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Living Lab Department, Broca Hospital

Paris, Île-de-France Region, 75013, France

About this study

This non-interventional and prospective study offers elderly people living at home the opportunity to host a social telepresence robot, for a period of three months, with the aim of maintaining a link with those around them and discovering activities offered by professionals (cooking, yoga, visiting virtual museum, etc.) via a networking platform.

This study consists of questionnaires and score calculations, assessing their feeling of loneliness and how they accept the robot in their home.

Subjects will be interviewed one week before the robot arrives at their home, at the start of the study (when the robot arrives).

The follow-up is carried out by a neuropsychologist at 6, 12 and 24 weeks of presence at home.

Data measuring loneliness and social isolation, memory, patient interaction with the robot, their quality of life as well as their emotions will be collected using questionnaires.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects aged at least 65 and living at home in Ile-de-France
  • Having expressed his non-opposition to his participation in the study
  • Agreeing to host a social telepresence robot at home
  • Having an internet connection at home

Exclusion criteria

  • Subject aged under 65 or not living at home in Ile-de-France
  • Having expressed his opposition to his participation in the study
  • With moderate / major cognitive impairment (Mini-mental state examination (MMSE) <20)
  • Placed under tutorship / curatorship
  • Whose housing surface is insufficient for reception and robot movements

Treatment and study plan

Social telepresence robot

Device

Use of a social telepresence robot at home, during three months with the aim of reducing the feeling of loneliness and social isolation among the elderly.

Primary outcomes

  1. Measuring subjective feelings of loneliness as well as feelings of social isolation according the UCLA Loneliness Scale

    Time frame: 24 weeks

  2. Measuring the perception of social support according Multidimensional Scale of Perceived Social Support

    Time frame: 24 weeks

Secondary outcomes

  1. Measuring the perceived usability of the robot's software according the System Usability Scale

    Time frame: 24 weeks

  2. Measuring technology acceptance according ALMERE questionnaire

    Time frame: 12 weeks

  3. Assessment of the impact of health according 12-Item Short Form Survey (SF-12) scale

    Time frame: 24 weeks

  4. Assessment of depressive state according Geriatric Depression Scale

    Time frame: 24 weeks

  5. Assessment positive and negative affect according the Positive Affect Negative Affect Scale (PANAS)

    Time frame: 24 weeks

  6. Assessment of the psycho-social impact of the device technology on the lives of users according The Psychosocial Impact of Assistive Devices Scales (PIADS)

    Time frame: 12 weeks

  7. Measuring the dimensions of the telepresence according Telepresence Temple Presence Inventory (TPI)

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

Gérond'if

Other

Registry information

Acronym: DOMIROB

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Feb 23, 2021
Registry last updated
Feb 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.